Basel Medical Group interim CFO files initial ownership

Basel Medical Group Ltd reports that interim CFO Neo Alton Chun How has filed an initial statement of beneficial ownership as an officer of the company.

Rhea-AI Filing Summary

Basel Medical Group Ltd reports that interim CFO Neo Alton Chun How has filed an initial statement of beneficial ownership as an officer of the company. The report shows no recorded transactions, acquisitions, dispositions, or holdings entries for the issuer’s securities in this filing.

Key Figures

Reported buy transactions: 0 shares Reported sell transactions: 0 shares Holding entries: 0

3 metrics

Reported buy transactions 0 shares Buy transactions in the initial ownership report

Reported sell transactions 0 shares Sell transactions in the initial ownership report

Holding entries 0 Number of reported holdings entries for issuer securities

Key Terms

Interim CFO, beneficial ownership, derivative securities

3 terms

Interim CFO financial

"Reporting person serves as Interim CFO of the issuer"

An interim CFO is a temporary chief financial officer hired to run a company’s finance operations during a leadership transition, a search for a permanent hire, or while specific financial issues are resolved. Investors pay attention because this person manages budgeting, financial reporting and communications with shareholders—like a substitute driver keeping a car on course—so their competence affects short‑term financial stability, the accuracy of public reports, and market confidence.

beneficial ownership regulatory

"Filed as an initial statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

derivative securities financial

"The filing’s derivative section is empty of derivative securities"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Basel Medical Group (BMGL) disclose in Neo Alton Chun How’s Form 3?

Basel Medical Group’s Form 3 for Neo Alton Chun How, its interim CFO, records no reportable transactions or holdings entries in the company’s securities, serving as his initial beneficial ownership statement as a company officer.

Who is the reporting person in Basel Medical Group (BMGL)’s latest Form 3?

The reporting person is Neo Alton Chun How, who serves as Interim CFO of Basel Medical Group Ltd. The Form 3 identifies him as an officer but does not list any transactions or holdings in issuer securities.

Does Basel Medical Group (BMGL) report any insider share purchases or sales in this Form 3?

No. The Form 3 shows 0 buy transactions and 0 sell transactions for interim CFO Neo Alton Chun How. The transaction summary reflects no acquisitions, dispositions, exercises, or gifts of Basel Medical Group securities.

Are any derivative securities reported for Basel Medical Group (BMGL) in this Form 3?

No derivative securities are listed. The filing’s derivative section is empty, and the transaction summary shows 0 derivative transactions and 0 exercise shares, indicating no derivatives are reported in this initial statement.

Does the Basel Medical Group (BMGL) Form 3 indicate significant insider holdings?

The Form 3 shows no holding entries for the reporting person. The transaction summary records zero transactions and zero net buy or sell shares, so no specific beneficial holdings are detailed in this initial officer filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/22/2026 - 06:58 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Neo Alton Chun How

(Last) (First) (Middle)

6 NAPIER ROAD,

UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)

SINGAPORE 258499

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/05/2026

3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Alton Neo Chun How	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)